Prevalence of antifolate resistance mutations in Plasmodium falciparum isolates in Afghanistan.
BACKGROUND: Artesunate plus sulphadoxine-pyrimethamine (AS+SP) is now first-line treatment for Plasmodium falciparum infection in several south Asian countries, including Afghanistan. Molecular studies provide a sensitive means to investigate the current state of drug susceptibility to the SP compon...
المؤلفون الرئيسيون: | Awab, G, Pukrittayakamee, S, Jamornthanyawat, N, Yamin, F, Dondorp, A, Day, N, White, N, Woodrow, C, Imwong, M |
---|---|
التنسيق: | Journal article |
اللغة: | English |
منشور في: |
BioMed Central
2013
|
مواد مشابهة
-
A population survey of the glucose-6-phosphate dehydrogenase (G6PD) 563C>T (Mediterranean) mutation in Afghanistan
حسب: Jamornthanyawat, N, وآخرون
منشور في: (2014) -
Polymorphisms in Plasmodium vivax antifolate resistance markers in Afghanistan between 2007 and 2017
حسب: Rakmark, K, وآخرون
منشور في: (2020) -
Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria.
حسب: Karema, C, وآخرون
منشور في: (2010) -
Clinical trials of artesunate plus sulfadoxine-pyrimethamine for Plasmodium falciparum malaria in Afghanistan: maintained efficacy a decade after introduction
حسب: Awab, GR, وآخرون
منشور في: (2016) -
A population survey of the glucose-6-phosphate dehydrogenase (G6PD) 563C>T (Mediterranean) mutation in Afghanistan.
حسب: Natsuda Jamornthanyawat, وآخرون
منشور في: (2014-01-01)